Screener
Phathom Pharmaceuticals, Inc. PHAT Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Phathom Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 7:05 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-324867
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Prepaid expenses and other current assets | 8,302 | 15,353 |
| Accounts receivable, net | 97,422 | 78,129 |
| Inventory | 7,713 | 5,518 |
| Total current assets | 295,915 | 228,972 |
| Property and equipment, net | 971 | 1,064 |
| Operating lease right-of-use assets | 2,410 | 2,603 |
| Restricted cash | 2,864 | 2,861 |
| Inventory, non-current | 21,827 | 20,732 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Phathom Pharmaceuticals, Inc.'s total current assets?
- Phathom Pharmaceuticals, Inc. (PHAT) reported total current assets of $295.92M in Q2 2026.
- How has Phathom Pharmaceuticals, Inc.'s total current assets changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s total current assets increased by 35.2% year-over-year, from $218.88M to $295.92M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Phathom Pharmaceuticals, Inc.'s total current assets has grown at a -4.7% compound annual growth rate (CAGR), from $291.37M to $228.97M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Phathom Pharmaceuticals, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude